Global Markets Direct Market Research Reports

TITLE Actions
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7....

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glycogen Sy...

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Protein K...

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Complement C5 (C3 And PZP Like Alph...

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is a tr...

Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Catenin Beta 1 - Drugs In Development, ...

Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glycoprotein 41 (gp41) pipeline Target constitutes close to 19 molecules. Out of which approximately...

20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary 20s Proteasome - 20S proteasome is the catalytic core of the 26S proteasome, the central protease of the ubi...

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published rep...

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline ...

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid...

Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Sep 2022 | US $ 3500 Onwards | By Global Markets Direct

Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Glucagon Like Peptide 2 Receptor - Dru...

Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Drugs In Deve...

Rotavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Rotavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rotavirus Infectio...

Rabies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Rabies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Drugs In Development, 2...

Chikungunya Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Chikungunya Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever - D...

Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2500 Onwards | By Global Markets Direct

Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Drugs In De...

Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menop...

Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Pompe Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease - Drugs In ...

Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Aug 2022 | US $ 2000 Onwards | By Global Markets Direct

Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Inclusion...

We are on:

Need Help?

Buy Any Report Avail 25% Discount. Coupon Code: DIS25

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K